StocksRunner logo
search
 
menu
 
 

52-Week High Breakout Stocks to Watch Right Now

 
  • user  Top.Gainers
  •  
     
      
     
     
     

    Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.

     
 
  • like  14 Nov 2025
  •  
 
 

Move Since

 
 
 

$CDTX Cidara Therapeutics explodes to new highs as reports surface of Merck nearing a multibillion-dollar acquisition. With volume surging far above average and RSI deep in overbought territory, momentum traders are watching this biotech rocket lead breakout list.

$ORI Old Republic edges into fresh-high territory following a bullish analyst upgrade that reinforces confidence in earnings resilience. Volume isn’t overwhelming, but the steady trend and renewed institutional optimism are enough to push ORI into new-high territory.

$MFG Mizuho Financial continues its slow grind higher, supported by renewed fintech, acquisition, and banking-sector interest. The stock breaks through its yearly ceiling even on lighter volume, reflecting gradual but persistent buying pressure.

$RVMD Revolution Medicines hits a perfect 52-week high print as enthusiasm builds around explosive growth forecasts for KRAS-targeting therapies. Strong RSI and persistent buying reinforce the position as a standout biotech momentum name today.

$IMNM Immunome taps new highs after multiple analyst initiations and bullish sentiment from major coverage firms. With improving volume relative to trend and a clean uptrend structure, IMNM continues to attract attention from growth-focused traders.

$SBS SBS extends its uptrend as investors react to progress in the Serra Pelada mining project. Today breakout reflects growing confidence in the operational developments and upside potential within the resource sector.

$OWLT Owlet prints a fresh high after delivering massive earnings and revenue beats, alongside higher full-year guidance. With strong RSI and rising interest from retail traders, OWLT breakout is fueled by fundamental upside and renewed growth conviction.

$CELC Celcuity pushes into new highs after five consecutive days of gains. The consistent buying streak signals strong accumulation, backed by solid volume and a firm uptrend that has traders eyeing follow-through momentum.

$APGE Apogee Therapeutics extends its breakout after multiple bullish analyst initiations and upbeat price-target outlooks. With strong volume support and an energetic uptrend, APGE continues to be one of the cleaner technical breakouts in the biotech space.

 
 

Unlock Exclusive Stock Insights!

Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.

Signup now for FREE and stay ahead of the market curve!


Why Join?

Find out what 10,000+ subscribers already know.

Real-time insights for informed decisions.

Limited slots available, SignUp Now!

 
Signup to Stocksrunner
 
 
 

Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.

 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive Our Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Our Services

Real-time stock market updates

Expert stock analysis

Investment strategies

Top stock recommendations

Trading signals and opportunities

 
About StocksRunner

Log In

Sign Up

Plans & Pricinig

Contact Us

Terms of use

Privacy Policy

 
 
 
StocksRunner

Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Subscribe to Our Daily Updates

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stocks analysis

Stocks trends

Stocks performance

Stocks analysis

Investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo